![Elmar R. Burchardt](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Elmar R. Burchardt
Corporate Officer/Principal bij
University of Witten/Herdecke
Profiel
Elmar R.
Burchardt is currently an Associate Professor at the University of Witten.
Previously, he held positions as the Chief Executive Officer & Director at TheraVitae, Inc., President, Chief Executive Officer & Director at Hemostemix, Inc., Medical Director at Miltenyi GmbH, Vice President-Medical Affairs at Vericel Corp., and Senior Research Group Leader at Bayer AG.
He obtained his graduate and doctorate degrees from Hannover Medical School.
Actieve functies van Elmar R. Burchardt
| Bedrijven | Functie | Begin |
|---|---|---|
University of Witten/Herdecke
 University of Witten/Herdecke Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Eerdere bekende functies van Elmar R. Burchardt
| Bedrijven | Functie | Einde |
|---|---|---|
| HEMOSTEMIX INC. | Algemeen Directeur | 25-01-2017 |
| VERICEL CORPORATION | Hoofd Techniek/Wetenschap/O&O | 30-05-2010 |
TheraVitae, Inc.
 TheraVitae, Inc. BiotechnologyHealth Technology Develops and commercializes adult stem cell technologies | Algemeen Directeur | - |
Miltenyi GmbH
 Miltenyi GmbH Financial ConglomeratesFinance Functions as an investment holding company | Hoofd Techniek/Wetenschap/O&O | - |
| BAYER AG | Corporate Officer/Principal | - |
Opleiding van Elmar R. Burchardt
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
14
Eerstegraads connecties
7
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 7 |
|---|---|
Vericel Corp.
 Vericel Corp. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which manufactures and markets two advanced cell therapy products for sports medicine and severe burn care | Health Technology |
Bayer AG
 Bayer AG Pharmaceuticals: MajorHealth Technology Provides health care, nutrition and high-tech material services | Health Technology |
TheraVitae, Inc.
TheraVitae, Inc. BiotechnologyHealth Technology Develops and commercializes adult stem cell technologies | Health Technology |
Miltenyi GmbH
Miltenyi GmbH Financial ConglomeratesFinance Functions as an investment holding company | Finance |
Hannover Medical School
 Hannover Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Witten/Herdecke
University of Witten/Herdecke Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Hemostemix, Inc.
 Hemostemix, Inc. BiotechnologyHealth Technology Develops, manufactures and commercializes blood-derived stem cell therapies for medical conditions | Health Technology |
